Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say - Reuters.com

Reuters | Nov. 1, 2023, 11:18 a.m. | Original
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say Reuters.com
US calls Indo-Pacific negotiating round just ahead of APEC summit - Reuters CVS tempers 2024 profit forecast on elevated medical costs, shares ... - Reuters.com